BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

COVID19

JN.1 Variant Takes Center Stage in Singapore's COVID-19 Resurgence

Surge in Cases and JN.1's Dominance From December 3 to 9, the number of COVID-19 cases in Singapore skyrocketed to 56,043, marking a staggering 7...

December 17, 2023 | News

Decoding JN.1: A Comprehensive Exploration of the Latest Covid-19 Variant

Symptoms of JN.1: Unmasking the Invisible Threat JN.1's clinical presentation mirrors that of Influenza-Like Illness (ILI), with patients commonly experien...

December 17, 2023 | News

Thermo Fisher Unveils Automated Solutions for Respiratory Testing

New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories. ...

December 12, 2023 | News

Novavax's COVID-19 Vaccine Now Available to All 194 WHO Member States

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced that Nuvaxovid™ XBB.1.5 ...

November 29, 2023 | News

China Faces Surge in 'Undiagnosed Pneumonia' Cases Among Children

The outbreak initially surfaced in northern China, prompting the World Health Organization (WHO) to issue an "official request" to ...

November 27, 2023 | News

Novavax's Nuvaxovid™ COVID-19 Vaccine Gains Full Approval in Singapore.

"The full approval of our prototype vaccine will enable us to file for approval of our updated protein-based non-mRNA COVID-19 vaccine in the coming w...

October 19, 2023 | News

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

October 04, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k)...

August 02, 2023 | News

New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation

Reeracoen, a leading provider of human resource services in Singapore, has released its latest report titled "Employee Attitudes Towards Di...

July 03, 2023 | News

Bergen Conference Marks 150 Years Since Discovery of the Leprosy Bacillus

Organized by the Sasakawa Leprosy (Hansen's Disease) Initiative and the University of Bergen, the conference in the city where Norwegian Dr. Armauer H...

June 23, 2023 | News

SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization

In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 parental strain and had a standard safety and reactogen...

June 19, 2023 | News

Novavax Set to Deliver Protein-based Monovalent XBB COVID Vaccine as per FDA VRBPAC Recommendation in Fall

Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale w...

June 16, 2023 | News

China Approves World's First Vaccine for XBB Descendent Lineages of SARS-CoV-2

WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...

June 12, 2023 | News

Stay Connected